chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling 50cm including both inj sites, soreness, warm, pink/redness in left upper arm/deltoid area.
Reportedly on 9/1/99, the pt experienced redness and hardness at the injection site on her left arm. The pt reportedly recovered from this experience.
headache; high blood pressure; bruise; A spontaneous report was received from a consumer concerning a 75-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache, high blood pressure, and bruise.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 9 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 030M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 11 Feb 2021, the patient experienced bad headache, high blood pressure and a bruise at injection site.  Treatment details included Amlodipine, pantoprazole.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), headache was unknown.The outcome of event(s), high blood pressure was unknown.The outcome of event(s), bruise was unknown..
tested positive for COVID-19 after receiving Pfizer vaccine; tested positive for COVID-19 after receiving Pfizer vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 85 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for COVID-19 after receiving Pfizer vaccine". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Whole-arm swelling.  Circumference of left deltoid (site of DTaP) measured today at 12:30 p.m.:  18.5 cm.  Right deltoid was 15.5 cm.
Was fine the first few days. Then 7 days (April 27th 2021) I had two small spots come up on my right arm near the injection site. They have gotten bigger since and are continuing to get bigger. Feel red, swollen, hot, painful, etc.
Developed rash all over torso 2 days after vaccine that lasted about 3 days. Took Benadryl for 1 or 2 days.
Patient c/o chills, body aches, low grade fever and nausea. Symptoms treated with Tylenol and warm compress.
This spontaneous report was received from an unspecified reporter via an online article published and refers to a 12995 patients of unknown age and gender who reported the events via Vaccine Adverse Event Reporting System. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses of quadrivalent HPV vaccine (manufacturer unknown) (dose, route of administration, anatomical location, lot # and expiration date were not reported). On unknown dates, the patients experienced unspecified adverse events that required an emergency room visits. The outcome of the events was unknown. The relatedness between the events and quadrivalent HPV vaccine (manufacturer unknown) was not reported. This is one of several reports received from the same reporter. Additional information is not expected as no contact details were provided.
extreme joint pain; severe muscle pain; headache; chills; nausea; This is a spontaneous report from a non-contactable consumer. A 74-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) intramuscularly on 03Feb2021 (at the age of 74-years-old) as a single dose for COVID-19 immunization. Medical history included Hashimoto's thyroiditis; osteoarthritis; and allergies to medications, food, or other products; all from unknown dates and unknown if ongoing. Prior to vaccination the patient was not diagnosed with COVID-19. Concomitant medications included meloxicam from an unknown date for osteoarthritis, which the patient had discontinued 2-3 days prior to immunization. The patient received the vaccine on 03Feb2021, the following day, 04Feb2021, the patient felt like she "got hit by a truck;" she complained of extreme joint pain, severe muscle pain, headache, chills and nausea. The events were reported as non-serious and did not require hospitalization. It was unknown if treatment was provided for the events. The patient reported she gradually improved over the next 3-4 days and resolved. The clinical outcomes of extreme joint pain, severe muscle pain, headache, chills, and nausea were recovered in Feb2021. It was also reported the patient had not been tested for COVID-19 since vaccination.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a nurse referring to multiple unspecified patients of unknown age and gender. On unknown dates, he patients were vaccinated with improperly stored doses of VAQTA 50/1.0 U/ML injection (lot # L018499, expiration 23-SEP-2016; lot # L028666, expiration 20-OCT-2016 and reported lot # K023529, expiration date 04-SEP-2016, dose and route unknown). No adverse events were reported. This is one of several reports received from the same source. Additional information has been requested.
pt states she had unusual taste sensation at time of injection.  She then felt a "weird feeling" in her chest area.  She desribed it as a pressure (not pain or inflammation).  We discussed treatments of ADR.  We opted to have her wait longer.  She stayed 37 min. During that time the pressure sensation moved lower in chest area and reduced in sensation.  She was feeling comfortable at that time and left pharmacy area.  RPh followed up 3/9 734 pm and she was doing well.
Acute Bronchitis (see copy)  Intial report contained record of a sick visit for acute bronchitis (cough, green sputum) on 11 May 2005. Txd with antibiotics, decongestants and cough medicine. Released without limitations. DX: Acute Bronchitis.  MR received from the VA. 2 Visits 2003 and then beginning May 2006.  F/U 08/2003 same, with normal labs.  Several visits between 05/2006 and 09/2006 for various c/o including marital problems, sleep disorder, depression, and  left wrist pain upon returning from Gulf War, also backache and varicocele (no tx needed).
Arm ache; Severe backache; Difficulty walking; This is a spontaneous report from a contactable consumer, the patient. A 77-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. Medical history included Chronic Obstructive Pulmonary Disease (COPD) and COVID-19 from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 12:30 (at the age of 77-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021 at 20:00, the patient experienced arm ache, severe backache and difficulty walking. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm ache, severe backache and difficulty walking were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
I had received the 1st dose of the vaccine on 12/22/2020. I tested positive for COVID 12/27/2020 and experienced mild symptoms such as mild fatigue and congestion. Thinking I had recovered from COVID I returned back to work as a RN on 1/9/2021.  I was told I could still get the 2nd dose of the vaccine if I still wanted to and that I should expect side effects of possible fevers, chills, fatigue and that they can last up to 3 days. I went ahead and got my 2nd dose on 1/13/2021. By the next day I had chills and extreme fatigue. I was expecting it and thought it would go away by the next two days. By day 4 I was feeling just as bad and actually felt worse than I did when first testing positive for COVID. On 1/17/2021 I experienced shortness of breath and palpitations while getting dressed. I went to ED and was sent home. On 1/19/2021 I experienced similar symptoms while driving home from DR appointment. Went to ER again and was sent home and was told it was all post covid symptoms.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Severe, Systemic: Shakiness-Medium, Additional Details: Gave flu shot left arm, pt stood up and turned around tom receive Pfizer COVID vaccine, but became very ill. Nausea, dizziness, sweating, lightheaded.  I waited and did not give the COVID shot. I gave her a little water and had a fan blow on her.  Shortly thereafter the pt vomited into the trash can. I took her BP, with the automated machine and it was 97/71.   I sat with her for about 50 minutes until it passed. Her boyfriend arrived to drive her home.  I told him to take her to the hospital if
Numbness and tingling in left arm and face, grogginess following first dose of Pfizer-BioNTech COVID-19 vaccine 0.3 mL IM in left deltoid.  Went to the ED. Monitored for 3 hours. All symptoms have subsided except a tingling sensation running through the left arm. Provider evaluated the patient, and thought this was likely a vasovagal type reaction on 12/30/21, although patient still reports some symptoms as of 1/12/21.
Syncopal episode, eyes rolled back, extremely diaphoretic and not completely out. CODE EMERGENCY CALLED. 911 also called due to hx of lung ca with mets.
Exactly a week after the vaccine shot, I started a very heavy menstural period.  It was not time yet.  I am on birth control pills and I am very regular.  It's been a week and I am still on a heavy period.  It was so bad that I purchased a pregnancy test because I was having a miscarriage.   Test was negative.
Had shingles /was diagnosed / episode of shingles; Rash occured on the back of the head and around the ear; Swollen lymph nodes; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th July 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced shingles, rash and enlargement of lymph nodes. On an unknown date, the outcome of the shingles, rash and enlargement of lymph nodes were unknown.   It was unknown if the reporter considered the shingles, rash and enlargement of lymph nodes to be related to Shingrix.  Additional details were provided as follows: The patient had reported the events for himself. The patient received vaccine 2 months ago from the reporting date and experienced rash in his head and swollen lymph nodes, one or two weeks later he was diagnosed and physician told him that that was an episode of shingles. On the day of reporting, 29th September 2020, the patient received 2nd dose. The reporter was agreed to follow up via email.
I have headache.; I had lump under my armpit; I have been throwing  up.; my body rash real bad. I have from body and the neck and then my armpit. It's bad.; I feel real bad/I feel so horrible; My body hurt bad; I could not walk the pain is so bad ; Under my armpit it hurts real bad.; I left work because I was so sick; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received third booster dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as Dose 3 (Booster), Single for Covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, the patient experienced headache, had lump under my armpit, have been throwing  up, my body rash real bad. i have from body and the neck and then my armpit. it's bad, i feel real bad/i feel so horrible, my body hurt bad, i could not walk the pain is so bad, under my armpit it hurts real bad and i left work because i was so sick. The patient stated that this going to go away, cause they give me a paper telling me all the symptoms and patient had all the symptoms but patients question was how long this going to be like this. The patient was not recovered from the events headache, I have been throwing up while the outcome of the events I had lump under my armpit, my body rash real bad. I have from body and the neck and then my armpit. It's bad, I feel real bad/I feel so horrible, My body hurt bad, I could not walk the pain is so bad ; Under my armpit it hurts real bad and I left work because I was so sick was reported as unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I woke up at 6:15am had a terrible headache, low fever 100.1. I took Tylenol for the headache and fever. Throughout the day exp muscle aches and joint pain. I also exp hot/cold flashes and fatigue. Around 6:00pm on 12/16 started to l feel better and was able to return to work on 12/17.
delayed menstrual period late by 1 week and light; delayed menstrual period late by 1 week and light; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 09:30 (at the age of 47-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included unspecified birth control medications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 24Apr2021, the patient experienced delayed menstrual period late by 1 week and light. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events delayed menstrual period late by 1 week and light was resolved on an unknown date in 2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
sore arm; low grade temp; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (sore arm) and BODY TEMPERATURE DECREASED (low grade temp) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and BODY TEMPERATURE DECREASED (low grade temp). At the time of the report, PAIN IN EXTREMITY (sore arm) and BODY TEMPERATURE DECREASED (low grade temp) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment drugs were reported.    This case was linked to MOD21-075527, MOD21-075517, MOD21-074055, MOD21-075351, MOD21-075500, MOD21-075532, MOD21-075540, MOD21-075544 (E2B Linked Report).; Sender's Comments:  MOD21-075527:Cross linked case MOD21-075517:Cross linked case MOD21-074055:Cross linked case MOD21-075351:Cross linked case MOD21-075500:Cross linked case MOD21-075532:Cross linked case MOD21-075540:Cross linked case MOD21-075544:Cross linked case
Face started to flush; Sick to her stomach; Did not sleep or feel well; Did not sleep or feel well; Aches and pains throughout her body; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Face started to flush), ABDOMINAL PAIN UPPER (Sick to her stomach), SLEEP DEFICIT (Did not sleep or feel well), FEELING ABNORMAL (Did not sleep or feel well) and MYALGIA (Aches and pains throughout her body) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FLUSHING (Face started to flush), ABDOMINAL PAIN UPPER (Sick to her stomach), SLEEP DEFICIT (Did not sleep or feel well), FEELING ABNORMAL (Did not sleep or feel well), MYALGIA (Aches and pains throughout her body) and HEADACHE (Bad headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. On 03-Feb-2021, FLUSHING (Face started to flush) had resolved. On 05-Feb-2021, ABDOMINAL PAIN UPPER (Sick to her stomach), SLEEP DEFICIT (Did not sleep or feel well), FEELING ABNORMAL (Did not sleep or feel well), MYALGIA (Aches and pains throughout her body) and HEADACHE (Bad headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
6 hours after shot temporarily lost hearing (muffled sound).; When it came back, pressure and ringing in ears.; Ears still have tinnitus and pressure issues.; Sensitivity to sound, which still causes pain.; When it came back, pressure and ringing in ears.; numbness in hands, face and feet; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 31-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0176, Expiry date: unknown), via an unspecified route of administration, administered in Arm Left on 06May2021 (at the age of 31-year-old) as single dose for COVID-19 immunization at Facility type vaccine: other. The patient medical history included lyme disease (healed). No other vaccine received by patient in four weeks and no other medications in two weeks. The patient had no known allergies. The patient's concomitant medications were not reported. It was reported as yes for covid prior to vaccination and no to covid tested post vaccination. The patient experienced 6 hours after shot temporarily lost hearing (muffled sound), when it came back, pressure and ringing in ears, ears still have tinnitus and pressure issues, sensitivity to sound, which still caused pain, numbness in hands, face and feet (occasional) on 06May2021. AE resulted in doctor or other healthcare professional office/clinic visit. Patient was treated for adverse events. Therapeutic measures were taken as a result of 6 hours after shot temporarily lost hearing (muffled sound), when it came back, pressure and ringing in ears, ears still have tinnitus and pressure issues, sensitivity to sound, which still causes pain, when it came back, pressure and ringing in ears, numbness in hands, face and feet. The clinical outcome of all events was not resolved.
On 1/11/2020 I got my second dose and the same night I started feeling sick it felt tired, I felt feverish but no fever, achy, headache, weak it felt like I had the flu it lasted 3 days.    Telehealth appointment with my doctor 1/12/2020
4 hours after vaccine, pt c/o throat swelling, trouble swallowing, dyspnea, sudden head congestion - took Ibuprofen and came back to doctor 10-18-07.
W/i 24 hours, migraine headache each GARDASIL since October. She has had body aches: pain, reports of clumsiness and tiredness. She started coming in for sick visit in early January due to nausea/vomiting. Now she reports periods of numbness and "not knowing where her legs are" and proprioception.
ITP (Immune Thrombocytopenia Purpura) developed - petechial rash noted, brought to clinic, had nosebleed, platelet count 4000. Started on steroids, platelet count 11,000 on 10/31/14.
pt exp vigorous crying for more than 3hrs, t101.7 x 24hrs, pain @ inj site;
Pt developed rash & exp febrile convuls; Mom stated pt turned blue & had to be resuscitated; Hospitalized for one day for observation; F/U exam revealed no evidence of further sz;
After approximately patient presented with a cough that was progressing, itching around the ears, jaw, neck & ankles.
Difficulty breathing; Swelling of face and Throat; Swelling of face and Throat; Loss of appetite; weakness; Tenderness; Pealing and breakage of skin in the same arm of the injection; Dizziness; Rash; Headaches; Body aches; Fatigue; Nausea; Along with pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite) and ASTHENIA (weakness) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (medications are not specified) and Abdominal pain on 01-Mar-2021.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite), ASTHENIA (weakness), TENDERNESS (Tenderness), INJECTION SITE DRYNESS (Pealing and breakage of skin in the same arm of the injection), DIZZINESS (Dizziness), RASH (Rash), HEADACHE (Headaches), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Nausea) and INJECTION SITE PAIN (Along with pain). At the time of the report, DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and Throat), PHARYNGEAL SWELLING (Swelling of face and Throat), DECREASED APPETITE (Loss of appetite), ASTHENIA (weakness), TENDERNESS (Tenderness), INJECTION SITE DRYNESS (Pealing and breakage of skin in the same arm of the injection), DIZZINESS (Dizziness), RASH (Rash), HEADACHE (Headaches), MYALGIA (Body aches), FATIGUE (Fatigue), NAUSEA (Nausea) and INJECTION SITE PAIN (Along with pain) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-215431 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up included date of birth, height and weight, and first and second dose information.